HIV-associated cancers

Missak Haigentz

doi:10.1007/978-3-319-15057-4_11

HIV-associated cancers

Missak Haigentz

Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The HIV/AIDS epidemic, now in its 4th decade, has seen major shifts in epidemiology, with survival of infected persons increasingly approximating that of the general population and resulting in an aging population increasingly susceptible to cancer. Furthermore, cancer, a historically important manifestation of HIV/AIDS, has also changed epidemiology over time, where the prevalence of the “non-AIDS-defining” cancers (including cancers of the lungs, liver, head and neck, and anus—all seen in excess among HIV-infected populations) now exceeds that of the AIDS-defining cancers (Kaposi sarcoma, non-Hodgkin lymphoma and cervical carcinoma). As approximately 9 % of LGBT persons aged 50 or older have HIV infection, cancer is an important heath concern and cause of mortality in this demographic. This chapter will review the current epidemiology and clinical considerations and treatment for HIV-associated malignancies as it pertains to LGBT populations.

Original language	English (US)
Title of host publication	Cancer and the LGBT Community
Subtitle of host publication	Unique Perspectives from Risk to Survivorship
Publisher	Springer International Publishing
Pages	169-186
Number of pages	18
ISBN (Electronic)	9783319150574
ISBN (Print)	9783319150567
DOIs	https://doi.org/10.1007/978-3-319-15057-4_11
State	Published - Jan 1 2015

ASJC Scopus subject areas

General Medicine
General Social Sciences
General Psychology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-319-15057-4_11

Cite this

@inbook{e7f4c82754d84f27ac0d16c32e678791,

title = "HIV-associated cancers",

abstract = "The HIV/AIDS epidemic, now in its 4th decade, has seen major shifts in epidemiology, with survival of infected persons increasingly approximating that of the general population and resulting in an aging population increasingly susceptible to cancer. Furthermore, cancer, a historically important manifestation of HIV/AIDS, has also changed epidemiology over time, where the prevalence of the “non-AIDS-defining” cancers (including cancers of the lungs, liver, head and neck, and anus—all seen in excess among HIV-infected populations) now exceeds that of the AIDS-defining cancers (Kaposi sarcoma, non-Hodgkin lymphoma and cervical carcinoma). As approximately 9 % of LGBT persons aged 50 or older have HIV infection, cancer is an important heath concern and cause of mortality in this demographic. This chapter will review the current epidemiology and clinical considerations and treatment for HIV-associated malignancies as it pertains to LGBT populations.",

author = "Missak Haigentz",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-15057-4_11",

language = "English (US)",

isbn = "9783319150567",

pages = "169--186",

booktitle = "Cancer and the LGBT Community",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - HIV-associated cancers

AU - Haigentz, Missak

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The HIV/AIDS epidemic, now in its 4th decade, has seen major shifts in epidemiology, with survival of infected persons increasingly approximating that of the general population and resulting in an aging population increasingly susceptible to cancer. Furthermore, cancer, a historically important manifestation of HIV/AIDS, has also changed epidemiology over time, where the prevalence of the “non-AIDS-defining” cancers (including cancers of the lungs, liver, head and neck, and anus—all seen in excess among HIV-infected populations) now exceeds that of the AIDS-defining cancers (Kaposi sarcoma, non-Hodgkin lymphoma and cervical carcinoma). As approximately 9 % of LGBT persons aged 50 or older have HIV infection, cancer is an important heath concern and cause of mortality in this demographic. This chapter will review the current epidemiology and clinical considerations and treatment for HIV-associated malignancies as it pertains to LGBT populations.

AB - The HIV/AIDS epidemic, now in its 4th decade, has seen major shifts in epidemiology, with survival of infected persons increasingly approximating that of the general population and resulting in an aging population increasingly susceptible to cancer. Furthermore, cancer, a historically important manifestation of HIV/AIDS, has also changed epidemiology over time, where the prevalence of the “non-AIDS-defining” cancers (including cancers of the lungs, liver, head and neck, and anus—all seen in excess among HIV-infected populations) now exceeds that of the AIDS-defining cancers (Kaposi sarcoma, non-Hodgkin lymphoma and cervical carcinoma). As approximately 9 % of LGBT persons aged 50 or older have HIV infection, cancer is an important heath concern and cause of mortality in this demographic. This chapter will review the current epidemiology and clinical considerations and treatment for HIV-associated malignancies as it pertains to LGBT populations.

UR - http://www.scopus.com/inward/record.url?scp=84943614121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943614121&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-15057-4_11

DO - 10.1007/978-3-319-15057-4_11

M3 - Chapter

AN - SCOPUS:84943614121

SN - 9783319150567

SP - 169

EP - 186

BT - Cancer and the LGBT Community

PB - Springer International Publishing

ER -

HIV-associated cancers

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this